First published online December 9, 2005
Journal of Cell Science 118, 2402e (2005)
© The Company of Biologists Limited
CNS stem cells: fate rewound
Stem cells from the central nervous system (CNS) can differentiate into neurons and glia in vitro, which makes them a potential source of material for treatment of nervous system damage. Ronald McKay and co-workers now report, however, that late embryonic and adult CNS stem cells can also generate neural-crest-like cells and choroid plexus mesenchyme, even though CNS fate specification occurs early in development (see p. 5849). The authors show that CNS stem cells from the cortex of 14.5- and 18.5-day-old rat embryos and from adult brains undergo an epithelial-mesenchymal transition to a neural-crest-like state and then differentiate into smooth-muscle and non-CNS glial cells when exposed to both fibroblast growth factor 2 (FGF2) and bone morphogenetic protein 2 (BMP2). Surprisingly, FGF2 is required for the BMP-mediated dorsal respecification of CNS stem cells independently of its mitogenic effects. The authors conclude that FGF2, a commonly used mitogen in vitro, acts as a permissive signal that allows CNS stem cells to respond to other instructive cues. This may explain why cultured stem cells sometimes generate more cell types than usually seen in vivo.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
- BMP2 and FGF2 cooperate to induce neural-crest-like fates from fetal and adult CNS stem cells
- Martin H. M. Sailer, Thomas G. Hazel, David M. Panchision, Daniel J. Hoeppner, Martin E. Schwab, and Ronald D. G. McKay
JCS 2005 118: 5849-5860.
[Abstract]
[Full Text]